Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiro Tatetsu

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Experimental Hematology|July 2, 2019
Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465)Hiro Tatetsu, Myriam Armant, Fei Wang, et al.
Cancer Reports (Hoboken, N.J.)|November 27, 2025
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel ManufacturingTaichi Hirano, Hiro Tatetsu, Shikiko Ueno, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor]Takahisa Nakamura, Jun-Ichirou Yasunaga, Kiho Yokoo, et al.
British Journal of Haematology|May 24, 2022
Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphomaTakafumi Shichijo, Kisato Nosaka, Hiro Tatetsu, et al.
Clinical and Translational Medicine|July 28, 2023
Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndromeHiro Tatetsu, Miho Watanabe, Jun Liu, et al.
International Journal of Hematology|July 30, 2009
Bone marrow large B cell lymphoma bearing cyclin D3 expression: clinical, morphologic, immunophenotypic, and genotypic analyses of seven patientsJyuri Watanuki, Kinta Hatakeyama, Takashi Sonoki, et al.
Biochemical and Biophysical Research Communications|November 14, 2018
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cellsShinya Endo, Nao Nishimura, Yawara Kawano, et al.
Leukemia Research Reports|September 11, 2023
Waldenstrom's macroglobulinemia-like B cell lymphoma with MYD88 L265P mutation and t(14;18)(q32;q21) involving IGH<i>-</i>MALT1Rie Furuta, Hiro Tatetsu, Jun-Ichirou Yasunaga, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|November 29, 2023
Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapyTaichi Hirano, Hiro Tatetsu, Shikiko Ueno, et al.
British Journal of Haematology|October 23, 2025
Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphomaTakafumi Shichijo, Hiro Tatetsu, Yusuke Higuchi, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Experimental Hematology|July 2, 2019
Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465)Hiro Tatetsu, Myriam Armant, Fei Wang, et al.
Cancer Reports (Hoboken, N.J.)|November 27, 2025
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel ManufacturingTaichi Hirano, Hiro Tatetsu, Shikiko Ueno, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor]Takahisa Nakamura, Jun-Ichirou Yasunaga, Kiho Yokoo, et al.
British Journal of Haematology|May 24, 2022
Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphomaTakafumi Shichijo, Kisato Nosaka, Hiro Tatetsu, et al.
Clinical and Translational Medicine|July 28, 2023
Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndromeHiro Tatetsu, Miho Watanabe, Jun Liu, et al.
International Journal of Hematology|July 30, 2009
Bone marrow large B cell lymphoma bearing cyclin D3 expression: clinical, morphologic, immunophenotypic, and genotypic analyses of seven patientsJyuri Watanuki, Kinta Hatakeyama, Takashi Sonoki, et al.
Biochemical and Biophysical Research Communications|November 14, 2018
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cellsShinya Endo, Nao Nishimura, Yawara Kawano, et al.
Leukemia Research Reports|September 11, 2023
Waldenstrom's macroglobulinemia-like B cell lymphoma with MYD88 L265P mutation and t(14;18)(q32;q21) involving IGH<i>-</i>MALT1Rie Furuta, Hiro Tatetsu, Jun-Ichirou Yasunaga, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|November 29, 2023
Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapyTaichi Hirano, Hiro Tatetsu, Shikiko Ueno, et al.
British Journal of Haematology|October 23, 2025
Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphomaTakafumi Shichijo, Hiro Tatetsu, Yusuke Higuchi, et al.
Pageof 5